LaserOptec (CEOs Hong Joo and Changjin Lee), a company specializing in skin beauty and disease treatment laser devices, announced on the 9th that it is pursuing a paid-in capital increase of 11.8 billion won.
The company's board of directors approved a paid-in capital increase through a public offering of forfeited shares after allocating shares to shareholders. The projected issue price is 4,580 won per share, and the number of shares to be issued is 2.58 million. Existing shareholders will be granted subscription rights based on their stakes, and any forfeited shares generated after subscription will be allocated through the public offering.
This paid-in capital increase is a preemptive measure to strengthen the company's mid- to long-term growth strategy and financial stability. The funds will be used for raw material purchases, new product research and development, and marketing, ensuring production and supply stability and mitigating cost fluctuation risks. Furthermore, the company plans to expand investments in R&D and marketing to strengthen its mid- to long-term sales base and enhance its competitiveness in the global market.
Lee Chang-jin, CEO of LaserOptics, said, “This paid-in capital increase is a strategic decision to strengthen financial soundness and pursue a mid- to long-term growth strategy amidst a highly volatile external environment.” He added, “We will enhance shareholder value by efficiently and transparently executing funds within the scope of minimizing dilution of existing shareholders’ stake.”
- See more related articles
You must be logged in to post a comment.